Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

被引：2
作者：
Zhu, Ling-ling [1 ]
Feng, Zhi-jun [2 ]
Zhou, Quan [3 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Geriatr VIP Ward,Div Nursing, Hangzhou 310009, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Urol, Hangzhou 310009, Zhejiang, Peoples R China
[3] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Pharm, Hangzhou 310009, Zhejiang, Peoples R China
来源：
CLINICAL INTERVENTIONS IN AGING | 2015年 / 10卷
关键词：
ALFUZOSIN; 10; MG; EFFICACY; SUBTYPE; SAFETY; SELECTIVITY; MANAGEMENT; SILODOSIN;
D O I：
10.2147/CIA.S82435
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：621 / 622
页数：2
相关论文
共 50 条
[41]   LUTS in BPH Patients Silodosin for the Treatment of lower Urinary Tract Symptoms in Men with benign Prostatic Hyperplasia [J].
Praus, F. ;
Miernik, A. .
UROLOGE, 2019, 58 (07) :795-798
[42]   Comparison of Silodosin versus Tadalafil in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia [J].
Yoshida, Masaki ;
Origasa, Hideki ;
Seki, Narihito .
LUTS-LOWER URINARY TRACT SYMPTOMS, 2017, 9 (03) :176-186
[43]   Benign prostatic hyperplasia and lower urinary tract symptoms. A review of current evidence [J].
Carrero-Lopez, V. M. ;
Cozar-Olmo, J. M. ;
Minana-Lopez, B. .
ACTAS UROLOGICAS ESPANOLAS, 2016, 40 (05) :288-294
[44]   Silodosin: a new subtype selective alpha-1 antagonist for the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia [J].
Osman, Nadir I. ;
Chapple, Christopher R. ;
Cruz, Francisco ;
Desgrandchamps, Francois ;
Llorente, Carlos ;
Montorsi, Francesco .
EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (14) :2085-2096
[45]   Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) [J].
Yu, Hong-Jeng ;
Lin, Alex Tong-Long ;
Yang, Stephen Shei-Dei ;
Tsui, Ke-Hung ;
Wu, Hsi-Chin ;
Cheng, Chen-Li ;
Cheng, Hong-Lin ;
Wu, Tony T. ;
Chiang, Po-Hui .
BJU INTERNATIONAL, 2011, 108 (11) :1843-1848
[46]   Combination of phosphodiesterase-5 inhibitors and α-blockers in patients with benign prostatic hyperplasia:: treatments of lower urinary tract symptoms, erectile dysfunction, or both? [J].
Carson, CC .
BJU INTERNATIONAL, 2006, 97 :39-43
[47]   Effects of tadalafil on storage and voiding function in patients with male lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A urodynamic-based study [J].
Matsukawa, Yoshihisa ;
Majima, Tsuyoshi ;
Matsuo, Kazuna ;
Funahashi, Yasuhito ;
Kato, Masashi ;
Yamamoto, Tokunori ;
Gotoh, Momokazu .
INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (03) :246-250
[48]   Prostatic Urethral Lift: A New Minimally Invasive Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia [J].
Bozkurt, Aliseydi ;
Karabakan, Mehmet ;
Keskin, Ercument ;
Hirik, Erkan ;
Balci, M. B. Can ;
Nuhoglu, Baris .
UROLOGIA INTERNATIONALIS, 2016, 96 (02) :202-206
[49]   Efficacy of newer medications for lower urinary tract symptoms attributed to benign prostatic hyperplasia: a systematic review [J].
MacDonald, Roderick ;
Brasure, Michelle ;
Dahm, Philipp ;
Olson, Carin M. ;
Nelson, Victoria A. ;
Fink, Howard A. ;
Risk, Michael C. ;
Rwabasonga, Bruce ;
Wilt, Timothy J. .
AGING MALE, 2019, 22 (01) :1-11
[50]   Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) [J].
Berges, Richard ;
Hoefner, Klaus ;
Gedamke, Michael ;
Oelke, Matthias .
WORLD JOURNAL OF UROLOGY, 2014, 32 (05) :1163-1170
12345